20
Emcure Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is FELBAMATE USP, with a corresponding US DMF Number 29408.
Remarkably, this DMF maintains an Active status since its submission on June 26, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 02, 2015, and payment made on July 08, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II